Y, T., Y, H., & L, W. (2024, November). Hsa_circ_0078767 Enhances Osteosarcoma Chemoresistance to Doxorubicin Through the Regulation of the miR-188-3p/GPX4 Axis. Pharmacogenomics and Personalized Medicine.
Chicago Style (17th ed.) CitationY, Tang, He Y, and Wu L. "Hsa_circ_0078767 Enhances Osteosarcoma Chemoresistance to Doxorubicin Through the Regulation of the MiR-188-3p/GPX4 Axis." Pharmacogenomics and Personalized Medicine Nov. 2024.
MLA (9th ed.) CitationY, Tang, et al. "Hsa_circ_0078767 Enhances Osteosarcoma Chemoresistance to Doxorubicin Through the Regulation of the MiR-188-3p/GPX4 Axis." Pharmacogenomics and Personalized Medicine, Nov. 2024.
Warning: These citations may not always be 100% accurate.
